<DOC>
	<DOCNO>NCT00138437</DOCNO>
	<brief_summary>The purpose study determine factor contribute continued incidence leprosy Colombia . Study participant include volunteer consent individual , old 4 year age , represent three study group : 1. healthy person know contact leprosy patient 2. patient report Instituto Colombiano de Medicina Tropical-CES Impresa Social del Estado Sanatorio Agua de Dios new diagnosis leprosy relapse leprosy 3. household contact leprosy patient describe group 2 . Blood , nasal swab , slit skin smear , biopsy take volunteer learn strain leprosy-causing bacteria area , immune response ( body 's response disease ) local resident bacteria , pattern leprosy transmission . Individuals participate study 1-10 day , study last 3 year .</brief_summary>
	<brief_title>Molecular Immunological Tools Detection Strain Diversity , Drug Resistance Immunological Responses</brief_title>
	<detailed_description>The overall objective study understand factor lead continued incidence leprosy Colombia novel molecular methodology use combination retrospective prospective sampling approach use three study group . Specific objective : ( 1 ) strain type M. leprae isolates obtain newly diagnose leprosy patient household contact ( HHCs ) Colombia identify cluster transmission pattern combine conventional epidemiological criterion ; ( 2 ) determine viability M. leprae mRNA detection specimen collect new leprosy patient HHCs ; ( 3 ) identify determine extent mutation confer resistance past circulate M. leprae isolates leprosy patient two Multidrug therapy ( MDT ) drug ; dapsone rifampicin ; ( 4 ) detect chain transmission endemic population retrospective analysis isolate sample bank combine strain type information new case conventional epidemiological criterion ; ( 5 ) detect , compare , delineate immune response profile M. leprae antigens biomarkers early detection leprosy prediction clinical outcome ( susceptible , infected , resistant individual ) among three study group . Study participant prospective sample collection include volunteer consent individual old 4 year age , represent three study group : ( 1 ) healthy person know contact leprosy patient , ( 2 ) patient report Instituto Colombiano de Medicina Tropical-CES ( ICMT-CES ) Impresa Social del Estado Sanatorio Agua de Dios diagnosis leprosy and/or relapse leprosy , ( 3 ) household contact ( HHC ) leprosy patient report Instituto Colombiano de Medicina Tropical-CES ( ICMT-CES ) Impresa Social del Estado Sanatorio Agua de Dios . Blood , nasal swab , slit skin smear biopsy obtain prospectively individual great 4 year age represent three study group : newly diagnose relapse leprosy patient , household contact ; healthy person know contact leprosy patient . Retrospective archive sample past present leprosy patient include available . DNA RNA base methodology develop applied obtain data necessary substantiation number factor implicate transmission leprosy Colombia . Nucleic acid base molecular method like Multiple Locus Variable number tandem repeat Analysis ( MLVA ) Single Nucleotide Polymorphisms ( SNPs ) perform strain typing M. leprae , combination epidemiological information delineate distribution type organism various region Colombia . Other DNA marker mutation cause drug resistance also collect M. leprae contain specimen . Due lack method cultivate M. leprae , viability organism newly collect biological sample test mRNA detection . A database generate include M. leprae genotype , patient history ( clinical demographic ) comprehensive epidemiological analysis monitor prevail M. leprae population structure reflective short long range dissemination ; correlation disease type genotype ; track evolutionary transmission pattern . Profiling host immunological response infection M. leprae do detection panel cytokine level mRNA and/or protein , detection antibody M. leprae antigen leprosy patient , household contact healthy individual know history contact leprosy patient .</detailed_description>
	<mesh_term>Leprosy</mesh_term>
	<criteria>All leprosy patient ( Group1 ) , household contact ( Group 2 ) healthy person know contact leprosy patient ( Group 3 ) , age 18 70 year willing participate study . Patients unwilling participate unable give inform consent exclude study . Pregnant woman exclude . Exclusion criterion objective A.5 one follow condition : Chronic illness cancer Diabetes Hepatitis HIV Tuberculosis Undergoing corticosteroid therapy Current previous history immunosuppressive therapy assess medical record interview physician .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>leprosy</keyword>
	<keyword>Colombia</keyword>
</DOC>